The Use of Telemedicine in Cancer Clinical Trials: Connect-Patient-to-Doctor Prospective Study
BackgroundTelemedicine is currently being adopted for the management of patients in routine care. However, its use remains limited in the context of clinical trials. ObjectiveThis study aimed to demonstrate the feasibility of telemonitoring and patient-reported ou...
Main Authors: | Yasmine Meghiref, Charles Parnot, Claire Duverger, Françoise Lilly Difoum, Audrey Gourden, Halima Yssaad, Caroline Leiterer, Caroline Bedekovic, Julien Blanchard, Houria Nait Ammar, Antoine Schernberg, Hélène Vanquaethem, Carole Helissey |
---|---|
Format: | Article |
Language: | English |
Published: |
JMIR Publications
2022-01-01
|
Series: | JMIR Cancer |
Online Access: | https://cancer.jmir.org/2022/1/e31255 |
Similar Items
-
Prognostic factors of toxicity of immune checkpoint inhibitors in nonsmall cell lung cancer and small cell lung cancer patients: The ToxImmune study
by: Francoise Difoum, et al.
Published: (2023-07-01) -
Effectiveness of electronic patient reporting outcomes, by a digital telemonitoring platform, for prostate cancer care: the Protecty study
by: C. Helissey, et al.
Published: (2023-05-01) -
Correlation Between Serum and Urine Biomarkers and the Intensity of Acute Radiation Cystitis in Patients Treated With Radiation Therapy for Localized Prostate Cancer: Protocol for the Radiotoxicity Bladder Biomarkers (RABBIO) Study
by: Carole Helissey, et al.
Published: (2023-01-01) -
DOCTORS’ ATTITUDE TO TELEMEDICINE
by: A.I. VVEDENSKIY, et al.
Published: (2021-09-01) -
DOCTOR'S PROFESSIONAL COMPETENCES IN TELEMEDICINE
by: E.I. AKSYONOVA, et al.
Published: (2021-09-01)